Abiraterone Acetate contains not less than 98.0% and not more than 102.0% of C26H33NO2.

共有 1 個藥物證書使用此成份

醋酸艾比瑞特隆
Abiraterone Acetate

• 申請商: 新雙隆生技股份有限公司
• 適應症: 轉移性前列腺癌用藥
• 發證日期: 2019-12-12